Cargando…
Cutaneous Cell-Mediated Delayed Hypersensitivity to Intravitreal Bevacizumab
The literature contains few reports describing autoimmune reactions to intravitreal bevacizumab and no Type-IV delayed hypersensitivity reactions. This was unexpected, as administration of intravenous bevacizumab has frequently caused dermatologic side-effects. This difference was likely attributabl...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813138/ https://www.ncbi.nlm.nih.gov/pubmed/33488016 http://dx.doi.org/10.4103/meajo.MEAJO_123_20 |